The effect of Metformin on complication of strokes
Phase 2
Recruiting
- Conditions
- Stroke.Stroke, not specified as haemorrhage or infarction
- Registration Number
- IRCT20160318027097N5
- Lead Sponsor
- Vice Chancellor for research of Ardebil University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Ischemic stroke patients; focal neurological symptoms.
Exclusion Criteria
intracerebral hemorrhage (ICH); subarachnoid hemorrhage (SAH); subdural hematoma (SDH); hypoglycemia; contraindications for metformin use; diabetic patients; venous sinus thrombosis; drug side effects.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The stroke clinical manifestations. Timepoint: Befor the intervention, 24 hours, 48 hours, 168 hours, 1 month, 2 months, 3 months after the intervention. Method of measurement: National Institutes Of Health Stroke Scale.
- Secondary Outcome Measures
Name Time Method -. Timepoint: -. Method of measurement: -.